Alphacentric Lifesci Healthcare Fund Investor Sentiment

LYFAX Fund  USD 13.51  0.10  0.75%   
Slightly above 52% of Alphacentric Lifesci's investor base is interested to short. The analysis of overall sentiment of trading Alphacentric Lifesci Healthcare mutual fund suggests that many investors are impartial at this time. Alphacentric Lifesci's investing sentiment can be driven by a variety of factors including economic data, Alphacentric Lifesci's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
Form N-CSRS MUTUAL FUND SERIES TRUST For Sep 30 - StreetInsider.com
Google News at Macroaxis
over a year ago at news.google.com         
Federal Home Loan Bank of Dallas Provides 1 million for Arkansas and Mississippi Storm Recovery - Ya...
Google News at Macroaxis
a day ago at seekingalpha.com         
Gilead acquires investigational HIV vaccine from Spanish biotech Aelix
seekingalpha News
3 days ago at nypost.com         
The 38 best books for Christmas 2024
news
few days ago at businesswire.com         
The Childrens Inn at NIH Announces 1 Million Grant From Gilead Sciences, Inc.
businesswire News
few days ago at thelincolnianonline.com         
Gilead Sciences, Inc. Shares Sold by Tradewinds LLC.
news
few days ago at finance.yahoo.com         
FirstLight and Maine Connectivity Authority Sign Agreement to Build 450 Miles of Fiber in Western Ma...
Yahoo News
few days ago at finance.yahoo.com         
Mt. Gilead KOA Holiday Named Kampgrounds of America, Inc.s 2025 Campground of the Year
Yahoo News
six days ago at businesswire.com         
TOUCH, la Alianza de Personas de la Raza Negra contra el Cncer de Seno y sus aliados presentan el ce...
businesswire News
six days ago at investing.com         
arcellx CFO Michelle Gilson sells 156,508 in shares
Investing News at Macroaxis
over a week ago at zacks.com         
FDA Accepts SNY and REGNs Dupixent Re-Submitted sBLA for Urticaria
zacks News
over a week ago at thelincolnianonline.com         
Linscomb Wealth Inc. Cuts Stock Holdings in Gilead Sciences, Inc.
news
a day ago at investing.com         
Acquisition by Thornberry Nancy of 1571 shares of Vertex Pharmaceuticals at 9.71 subject to Rule 16b...
Investing News at Macroaxis
3 days ago at thelincolnianonline.com         
Pacer Advisors Inc. Sells 5,885 Shares of Vertex Pharmaceuticals Incorporated
news
few days ago at finance.yahoo.com         
Goldman Sachs Vertex Pharmaceuticals Incorporated Is A Top Growth Investor Stock
Yahoo News
few days ago at dailygalaxy.com         
Extinct for 16 Million Years, This Ancient Species Returns to Stun Scientists
news
few days ago at investing.com         
Vertex trust sells 3.79 million in shares
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Cision to Transform AI-Powered Communications in Collaboration with Google Cloud
Yahoo News
few days ago at forbes.com         
Buy Signal Flashing For Struggling Biotech
Usa forbes News
six days ago at zacks.com         
Vertex Pharmaceuticals Incorporated is Attracting Investor Attention Here is What You Should Know
zacks News
six days ago at gurufocus.com         
Disposition of tradable shares by Altshuler David of Vertex Pharmaceuticals at 478.56 subject to Rul...
Gurufocus Stories at Macroaxis
over a week ago at investing.com         
Vertex CEO David DeStefano sells 9.8 million in shares
Investing News at Macroaxis
3 days ago at investing.com         
Viracta Therapeutics faces Nasdaq delisting risk
Investing News at Macroaxis
over a week ago at news.google.com         
Viracta Therapeutics Highlights Strategic Focus and Financials - TipRanks
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Sunesis Advisors LLC Sells 277 Shares of iShares SP Mid-Cap 400 Value ETF
news
over two months ago at thelincolnianonline.com         
Viracta Therapeutics, Inc. Short Interest Update
news
over three months ago at finance.yahoo.com         
Heres Why Sunesis Is a Great Buy the Bottom Stock Now
Yahoo News
over three months ago at news.google.com         
Viracta Therapeutics PT Lowered to 4.00 - Defense World
Google News at Macroaxis
over three months ago at benzinga.com         
Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday?
benzinga news
over three months ago at seekingalpha.com         
Viracta Therapeutics GAAP EPS of -0.25 beats by 0.11
seekingalpha News
over three months ago at finance.yahoo.com         
Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, an...
Yahoo News
over three months ago at news.google.com         
Viracta Therapeutics announces workforce reduction - Investing.com
Google News at Macroaxis
a day ago at finance.yahoo.com         
Pulmonary Arterial Hypertension Market Is Expected To Reach Revenue Of USD 13.2 Bn By 2033, At 5.6 p...
Yahoo News
few days ago at news.google.com         
Disposition of 7700 shares by Mahon Paul A of United Therapeutics at 367.36 subject to Rule 16b-3
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 237 shares by Michael Benkowitz of United Therapeutics at 362.0202 subject to Rule 16...
Macroaxis News
over a week ago at gurufocus.com         
Avoro Capital Advisors LLC Increases Stake in Ascendis Pharma AS
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
United Therapeutics Co. Director Judy D. Olian Sells 1,750 Shares
news
over two weeks ago at gurufocus.com         
United Therapeutics Stock Dips Amid Broader Biotech Industry Movements
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Lifestyle Asset Management Inc. Sells 95 Shares of United Therapeutics Co.
news
over two weeks ago at gurufocus.com         
Insider Sale Director Richard Giltner Sells 10,000 Shares of United Therapeutics Corp
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
HMS Capital Management LLC Buys New Shares in United Therapeutics Co.
news
over two weeks ago at gurufocus.com         
Insider Sale Director Christopher Causey Sells Shares of United Therapeutics Corp
Gurufocus Stories at Macroaxis
a minute ago at finance.yahoo.com         
Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Disease...
Yahoo News
3 days ago at www.macroaxis.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Macroaxis News
few days ago at www.macroaxis.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Macroaxis News
six days ago at investing.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Investing News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Macroaxis News
over a week ago at thelincolnianonline.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
news
over a week ago at gurufocus.com         
Capital International Investors Expands Stake in Sarepta Therapeutics Inc
Gurufocus Stories at Macroaxis
over a week ago at simplywall.st         
Sarepta Therapeutics Is Posting Healthy Earnings, But It Is Not All Good News
Simply Wall St News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
news
over two weeks ago at thelincolnianonline.com         
Sarepta Therapeutics Raised to Overweight at Cantor Fitzgerald
news
a day ago at finance.yahoo.com         
Neuroendocrine Tumors Market to Showcase Rapid Growth During the Study Period , at a CAGR of 5.1 Del...
Yahoo News
few days ago at businesswire.com         
BioFuture 2024 Wraps Up Hundreds of High-Profile Attendees Joined Record Numbers of Investors and Me...
businesswire News
few days ago at finance.yahoo.com         
BioFuture 2024 Wraps Up Hundreds of High-Profile Attendees Joined Record Numbers of Investors and Me...
Yahoo News
few days ago at finance.yahoo.com         
Dremio Ranked Number 268 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fa...
Yahoo News
few days ago at finance.yahoo.com         
Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies
Yahoo News
six days ago at thelincolnianonline.com         
Claro Advisors LLC Acquires 251 Shares of Regeneron Pharmaceuticals, Inc.
news
six days ago at finance.yahoo.com         
Heres Why Regeneron Pharmaceuticals Declined in Q3
Yahoo News
six days ago at insidermonkey.com         
Regeneron Pharmaceuticals, Inc. Among the Best Genomics Stocks to Buy Right Now
insidermonkey News
over a week ago at finance.yahoo.com         
FDA Accepts SNY and REGNs Dupixent Re-Submitted sBLA for Urticaria
Yahoo News
over a week ago at thelincolnianonline.com         
Natixis Advisors LLC Buys 319 Shares of Regeneron Pharmaceuticals, Inc.
news
few days ago at globenewswire.com         
uniQure Announces Dosing of First Patient in GenTLE Phase IIIa Clinical Trial of AMT-260 for the Tre...
Macroaxis News: globenewswire.com
few days ago at thelincolnianonline.com         
uniQure Announces Dosing of First Patient in GenTLE Phase IIIa Clinical Trial of AMT-260 for Refract...
news
over two weeks ago at thelincolnianonline.com         
Royal Bank of Canada Has Lowered Expectations for uniQure Stock Price
news
over two weeks ago at finance.yahoo.com         
What Does The Future Hold For uniQure N.V. These Analysts Have Been Cutting Their Estimates
Yahoo News
over two weeks ago at finance.yahoo.com         
UniQure Q3 Earnings Snapshot
Yahoo News
over three weeks ago at zacks.com         
Select Medical Q3 Earnings and Revenues Surpass Estimates
zacks News
over a month ago at thelincolnianonline.com         
uniQure Raised to Sell at StockNews.com
news
over a month ago at finance.yahoo.com         
uniQure Announces Dosing of First Patient in Phase III Clinical Trial of AMT-162 for the Treatment S...
Yahoo News
over a month ago at zacks.com         
Strength Seen in Dianthus Therapeutics, Inc. Can Its 5.7 percent Jump Turn into More Strength?
zacks News
over two months ago at www.macroaxis.com         
Acquisition by Gut Robert of 17060 shares of Uniqure NV at 20.18 subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Nivolumab Plus Relatlimab Induces Durable Responses in ... - OncLive
Google News at Macroaxis
a minute ago at finance.yahoo.com         
Merck and GTRI to develop gene therapy for Parkinsons disease
Yahoo News
2 days ago at thelincolnianonline.com         
Alpha DNA Investment Management LLC Acquires 1,254 Shares of Merck Co., Inc.
news
3 days ago at thelincolnianonline.com         
Merck Co., Inc. Shares Bought by Keyes Stange Wooten Wealth Management LLC
news
few days ago at gurufocus.com         
Merck Recommends Rejection of TRC Capitals Mini-Tender Offer
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Merck Co., Inc. Shares Acquired by Cypress Capital Group
news
few days ago at finance.yahoo.com         
Top Analyst Reports for Broadcom, Merck Qualcomm
Yahoo News
few days ago at finance.yahoo.com         
Merck Foundation Announces 17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
Yahoo News
six days ago at medcitynews.com         
Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda
news
over a week ago at finance.yahoo.com         
Johnson Johnson appoints CIO to lead business technology strategy
Yahoo News
over a week ago at thelincolnianonline.com         
Sather Financial Group Inc Has 814,000 Stock Position in Merck Co., Inc.
news
a minute ago at simplywall.st         
Jazz Pharmaceuticals investors are sitting on a loss of 20 percent if they invested a year ago
Simply Wall St News at Macroaxis
few days ago at finance.yahoo.com         
FDA Roundup November 22, 2024
Yahoo News
few days ago at benzinga.com         
FDA Greenlights Jazz Pharmas Cancer Drug, A Milestone For Zymework
benzinga news
few days ago at finance.yahoo.com         
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Est...
Yahoo News
six days ago at finance.yahoo.com         
Should Value Investors Buy Jazz Pharmaceuticals Stock?
Yahoo News
over a week ago at insidermonkey.com         
Is Jazz Pharmaceuticals plc the Best Immunotherapy Stock to Buy Now?
insidermonkey News
over a week ago at finance.yahoo.com         
Jazz Pharmaceuticals Performance Is Even Better Than Its Earnings Suggest
Yahoo News
over a week ago at zacks.com         
Is the Options Market Predicting a Spike in Jazz Stock?
zacks News
over a week ago at finance.yahoo.com         
Wall Street Analysts See a 37.65 percent Upside in Jazz Can the Stock Really Move This High?
Yahoo News
over a week ago at zacks.com         
Jazz Upgraded to Buy Heres Why
zacks News
a day ago at businesswire.com         
Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicu...
businesswire News
few days ago at insidermonkey.com         
Goldman Sachs Incyte Corporation Is A Top Growth Investor Stock
insidermonkey News
few days ago at zacks.com         
Biotech Stock Roundup SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval More
zacks News
few days ago at finance.yahoo.com         
Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4 percent by 2034 Delv...
Yahoo News
six days ago at smh.com.au         
ASX set to slip, global markets fall on rising Russia-Ukraine tensions
news
six days ago at seekingalpha.com         
Incyte pares some losses on report of potential Merck takeover interest
seekingalpha News
over a week ago at insidermonkey.com         
Is Incyt Corporation the Best Immunotherapy Stock to Buy Now?
insidermonkey News
over a week ago at finance.yahoo.com         
Heres How Jakafis Patent Expiry Impacts Incyte Corporations Growth Prospects
Yahoo News
over a week ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Eyenovia Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires New Stake in Iterum Therapeutics PLC
Gurufocus Stories at Macroaxis
a day ago at simplywall.st         
Have Immunovant Insiders Been Selling Stock?
Simply Wall St News at Macroaxis
few days ago at investing.com         
Immunovant CFO Eva Renee Barnett sells 106,228 in stock
Investing News at Macroaxis
six days ago at news.google.com         
Immunovant stock hits 52-week low at 24.66 amid market shifts - Investing.com
Google News at Macroaxis
over a week ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires New Stake in Trevena Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Armistice Capital, LLCs Strategic Acquisition in Accelerate Diagnostics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Immunovants Q2 Loss Wider Than Expected, Pipeline in Focus
zacks News
over three weeks ago at www.macroaxis.com         
Disposition of 2362 shares by Macias William L. of Immunovant at 29.64 subject to Rule 16b-3
Macroaxis News
over a month ago at investing.com         
Immunovants chief medical officer sells 94,171 in stock
Investing News at Macroaxis
over a month ago at investing.com         
Immunovants chief medical officer William Macias sells 91,782 in stock
Investing News at Macroaxis
over a month ago at investing.com         
Acquisition by Julia Butchko of 54978 shares of Immunovant subject to Rule 16b-3
Investing News at Macroaxis
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
few days ago at investing.com         
Galapagos stock downgraded to Reduce on strategic concerns
Investing News at Macroaxis
over a week ago at gurufocus.com         
Stonepine Capital Management Reduces Stake in Evolus Inc
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
Galapagos Sees Large Volume Increase Should You Buy?
news
over three weeks ago at gurufocus.com         
Galapagos NV Q3 2024 Earnings Call Highlights Strong Cash Position and RD Progress ...
Gurufocus Stories at Macroaxis
over three weeks ago at seekingalpha.com         
Galapagos Q3 2024 Earnings Preview
seekingalpha News
over three months ago at benzinga.com         
Why Trip.com Group Shares Are Trading Higher By Around 10 Here Are 20 Stocks Moving Premarket
benzinga news
over three months ago at finance.yahoo.com         
Galapagos Up on FDA Nod to Begin Phase III Lymphoma Study
Yahoo News
over three months ago at finance.yahoo.com         
ADAP 2Q24 Earnings Review Tecelra FDA Approval Capital Reload
Yahoo News
over three months ago at seekingalpha.com         
Galapagos pauses enrollment in Phase 12 study for GLPG5301
seekingalpha News
over three months ago at investorplace.com         
GLPG Stock Earnings Galapagos Beats EPS, Beats Revenue for Q2 2024
sbwire news
a day ago at gurufocus.com         
ACADIA HEALTHCARE COMPANY, INC. DEADLINE ALERT Bernstein Liebhard LLP Reminds ...
Gurufocus Stories at Macroaxis
few days ago at investing.com         
Acadia Pharmaceuticals announces executive shakeup
Investing News at Macroaxis
few days ago at investing.com         
Acadia Pharmaceuticals CFO sells shares worth 172,453
Investing News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 9913 shares by Mark Schneyer of ACADIA Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a week ago at businesswire.com         
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over a week ago at zacks.com         
Heres Why Acadia Pharmaceuticals is a Strong Momentum Stock
zacks News
over two weeks ago at prnewswire.com         
ACADIA HEALTHCARE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL KAHN SWICK FOTI, LLC REMIND...
prnewswire News
over two weeks ago at simplywall.st         
ACADIA Pharmaceuticals Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predi...
Simply Wall St News at Macroaxis
over two weeks ago at thelincolnianonline.com         
ACADIA Pharmaceuticals Posts Earnings Results
news
over two weeks ago at gurufocus.com         
ACADIA Pharmaceuticals Inc Q3 2024 Earnings Call Highlights Strong Sales Growth and ...
Gurufocus Stories at Macroaxis
a day ago at zacks.com         
Exelixis Stock Surges 25 percent in a Month Time to Buy or Sell?
zacks News
few days ago at zacks.com         
3 Reasons Growth Investors Will Love Exelixis
zacks News
few days ago at zacks.com         
Exelixis is a Top-Ranked Value Stock Should You Buy?
zacks News
few days ago at thelincolnianonline.com         
Insider Selling Exelixis, Inc. EVP Sells 41,588 Shares of Stock
news
over a week ago at www.macroaxis.com         
Disposition of 27224 shares by Peterson Amy C. of Exelixis at 35.05 subject to Rule 16b-3
Macroaxis News
over two weeks ago at zacks.com         
What Makes Exelixis a Strong Momentum Stock Buy Now?
zacks News
over two weeks ago at finance.yahoo.com         
Ryvu Therapeutics Reports 2024 Q3 Financial Results and Provides Corporate Update
Yahoo News
over two weeks ago at zacks.com         
Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook
zacks News
over two weeks ago at investing.com         
Exelixis EVP sells 1.7 million in stock
Investing News at Macroaxis
over two weeks ago at bizjournals.com         
Alameda company Exelixis puts more than 200,000 square feet up for sublease
bizjournals News
over a year ago at gurufocus.com         
Top 5 4th Quarter Trades of BP PLC
Gurufocus Stories at Macroaxis
2 days ago at news.google.com         
Collegium Pharmaceutical, Inc. Receives Average Recommendation of Moderate Buy from Brokerages - Mar...
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Empowered Funds LLC Acquires New Position in Collegium Pharmaceutical, Inc.
news
over a week ago at gurufocus.com         
Rubric Capital Management LP Adjusts Stake in Collegium Pharmaceutical Inc
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Is Collegium Pharmaceutical a Great Value Stock Right Now?
Yahoo News
over a week ago at gurufocus.com         
Collegium Pharmaceutical Inc Stock Price Down 3.67 percent on Nov 12
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Is the Options Market Predicting a Spike in Collegium Pharmaceutical Stock?
zacks News
over two weeks ago at finance.yahoo.com         
Collegium Pharmaceutical Inc Q3 2024 Earnings Call Highlights Record Revenue Growth and ...
Yahoo News
over two weeks ago at finance.yahoo.com         
Collegium Pharmaceutical Q3 Earnings Snapshot
Yahoo News
over two weeks ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Collegium Pharmaceutical Q3 Earnings
Yahoo News
over two weeks ago at gurufocus.com         
What To Expect From Collegium Pharmaceutical Inc Q3 2024 Earnings
Gurufocus Stories at Macroaxis
a day ago at investing.com         
Piper Sandler stays bullish on Cogent shares, cites clinical profile strength for bezu
Investing News at Macroaxis
over a week ago at thelincolnianonline.com         
What is Lifesci Capitals Forecast for COGT FY2024 Earnings?
news
over a week ago at investing.com         
Cogent shares target cut, retains buy rating on Q3 earnings
Investing News at Macroaxis
over two weeks ago at www.macroaxis.com         
Acquisition by Ros Matthew of 60000 shares of Cogent Biosciences at 8.45 subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.macroaxis.com         
Acquisition by Ros Matthew of 1900 shares of Cogent Biosciences at 10.75 subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC...
Yahoo News
over a month ago at www.macroaxis.com         
Acquisition by Ferrante Karen Jean of 2034 shares of Cogent Biosciences at 10.75 subject to Rule 16b...
Macroaxis News
over two months ago at news.google.com         
Cogent Biosciences price target raised to 15 from 13 at Citi - TipRanks
Google News at Macroaxis
over two months ago at simplywall.st         
Cogent Biosciences Is In A Good Position To Deliver On Growth Plans
Simply Wall St News at Macroaxis
over three months ago at news.google.com         
COGT Operating Margin percent 0.00 percent - GuruFocus.com
Google News at Macroaxis
3 days ago at news.google.com         
Coherus BioSciences Inc Q2 2024 Earnings Call Highlights Strong Revenue Growth and Strategic Advance...
Google News at Macroaxis
over two weeks ago at insidermonkey.com         
Coherus BioSciences, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over two weeks ago at thelincolnianonline.com         
HC Wainwright Reiterates Buy Rating for Coherus BioSciences
news
over two weeks ago at seekingalpha.com         
Coherus BioSciences Non-GAAP EPS of -0.01 beats by 0.10, revenue of 70.77M beats by 13.96M
seekingalpha News
over two weeks ago at seekingalpha.com         
Coherus BioSciences Q3 2024 Earnings Preview
seekingalpha News
over a month ago at thelincolnianonline.com         
Coherus BioSciences Upgraded at StockNews.com
news
over a month ago at finance.yahoo.com         
Coherus BioSciences, Inc. Worst 52-Week Low Stock to Buy Now
Yahoo News
over two months ago at thelincolnianonline.com         
Coherus BioSciences, Inc. Forecasted to Earn FY2028 Earnings of 0.08 Per Share
news
over two months ago at simplywall.st         
Coherus BioSciences, Inc. Has Found A Path To Profitability
Simply Wall St News at Macroaxis
over three months ago at news.google.com         
CHRS Enterprise Value 254.6 Mil - GuruFocus.com
Google News at Macroaxis
a day ago at finance.yahoo.com         
AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer
Yahoo News
few days ago at news.google.com         
Disposition of 9824 shares by Coats Lonnel of Blueprint Medicines at 94.87 subject to Rule 16b-3
Google News at Macroaxis
over a week ago at news.google.com         
Prime Capital Investment Advisors LLC Sells 6,476 Shares of Blueprint Medicines Co. - MarketBeat
Google News at Macroaxis
over a week ago at investing.com         
Blueprint Medicines stock underpriced with 2bn peak sales in sight, per JPMorgan
Investing News at Macroaxis
over two weeks ago at thelincolnianonline.com         
97,861 Shares in Blueprint Medicines Co. Bought by MG Plc
news
over three weeks ago at thelincolnianonline.com         
Blueprint Medicines Co. Shares Bought by Emerald Advisers LLC
news
over three weeks ago at thelincolnianonline.com         
Blueprint Medicines Buy Rating Reaffirmed at Needham Company LLC
news
over three weeks ago at thelincolnianonline.com         
Wedbush Boosts Earnings Estimates for Blueprint Medicines
news
over three weeks ago at thelincolnianonline.com         
Wedbush Research Analysts Lift Earnings Estimates for BPMC
news
over three weeks ago at zacks.com         
Blueprint Medicines Reports Q3 Loss, Tops Revenue Estimates
zacks News
a day ago at investing.com         
BridgeBios SWOT analysis genetic disease fighters stock faces pivotal moment
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Heres Why BioMarin Pharmaceutical is a Strong Value Stock
Yahoo News
few days ago at zacks.com         
Heres Why BioMarin Pharmaceutical is a Strong Growth Stock
zacks News
over a week ago at simplywall.st         
BioMarin Pharmaceutical Inc. Not Flying Under The Radar
Simply Wall St News at Macroaxis
over a week ago at thelincolnianonline.com         
WCM Investment Management LLC Buys 10,485 Shares of BioMarin Pharmaceutical Inc.
news
over a week ago at zacks.com         
Disposition of 5278 shares by Guyer Charles Greg of Biomarin Pharmaceutical at 66.3743 subject to Ru...
zacks News
over two weeks ago at businesswire.com         
RIBOMIC annonce des rsultats intermdiaires positifs dun essai de phase IIa sur lumedaptanib pegol da...
businesswire News
over two weeks ago at finance.yahoo.com         
RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplas...
Yahoo News
over two weeks ago at zacks.com         
Why BioMarin Pharmaceutical is a Top Value Stock for the Long-Term
zacks News
over two weeks ago at finance.yahoo.com         
Why BioMarin Pharmaceutical is a Top Growth Stock for the Long-Term
Yahoo News
a day ago at prnewswire.com         
WYNNEFIELD GROUP SENDS DEFINITIVE PROXY MATERIALS TO TECHPRECISION STOCKHOLDERS, INCLUDING A BLUE PR...
prnewswire News
six days ago at finance.yahoo.com         
Isle Blue Redefines Luxury Travel with Exclusive Miami Villa Collection
Yahoo News
over a week ago at gurufocus.com         
bluebird bio Inc Q3 2024 Earnings Call Highlights Navigating Revenue Challenges and ...
Gurufocus Stories at Macroaxis
over a week ago at investing.com         
Bluebird bio stock downgraded, price target slashed on financial update
Investing News at Macroaxis
over a week ago at bizjournals.com         
Bluebird bio says it needs cash to operate beyond March 2025
bizjournals News
over a week ago at gurufocus.com         
Goldman Sachs Group Incs Strategic Acquisition of Shares in bluebird bio Inc
Gurufocus Stories at Macroaxis
over two weeks ago at newswire.com         
Fusion Energy Agreement Between RSE and BLUE LASER FUSION
news
over two weeks ago at finance.yahoo.com         
Acquisition by Leschly Nick of 49850 shares of Bluebird Bio at 0.44 subject to Rule 16b-3
Yahoo News
over two weeks ago at gurufocus.com         
Vanguard Group Incs Strategic Acquisition of Shares in bluebird bio Inc
Gurufocus Stories at Macroaxis
over two weeks ago at businesswire.com         
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cel...
businesswire News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
few days ago at finance.yahoo.com         
Goldman Sachs Biogen Inc. Is A Top Growth Investor Stock
Yahoo News
few days ago at investing.com         
Sage shares target cut, maintains hold on failed drug study
Investing News at Macroaxis
few days ago at benzinga.com         
Biogen Unusual Options Activity For November 20
benzinga news
six days ago at finance.yahoo.com         
Immunomodulators Market to hit USD 388.7 billion by 2032, says Global Market Insights Inc.
Yahoo News
over a week ago at thelincolnianonline.com         
Biogen Sets New 12-Month Low Should You Sell?
news
over a week ago at finance.yahoo.com         
Needham downgrades Biogen on slow growth of Alzheimers drug
Yahoo News
over a week ago at benzinga.com         
Biogens Outlook Dims As Analyst Projects Flat Revenue Until 2026
benzinga news
over a week ago at thelincolnianonline.com         
Robert W. Baird Forecasts Strong Price Appreciation for Biogen Stock
news
over a week ago at statnews.com         
STAT Pharmalittle Were reading about an Alzheimers drug about-face, Bavarian Nordics views on Trump,...
news
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
few days ago at news.google.com         
Allakos Reports Q3 2024 Results and Research Progress - TipRanks
Google News at Macroaxis
over a week ago at news.google.com         
FMR LLCs Strategic Acquisition of Allakos Inc Shares - GuruFocus.com
Google News at Macroaxis
over a month ago at simplywall.st         
Allakos Insiders Miss 24 percent Gain After Offloading Stock
Simply Wall St News at Macroaxis
over a month ago at thelincolnianonline.com         
JMP Securities Reaffirms Market Outperform Rating for Allakos
news
over two months ago at news.google.com         
Allakos stock plunges to 52-week low of 0.56 amid market challenges - Investing.com
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Disposition of 13665 shares by Radford Harlan Baird of Allakos at 0.65 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Vanguard Group Inc. Raises Stock Holdings in Allakos Inc. - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Allakos stock plunges to 52-week low of 0.67 amid steep annual decline - Investing.com
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
Yahoo News
over three months ago at finance.yahoo.com         
Can Allakos Afford To Invest In Growth?
Yahoo News
over a year ago at news.google.com         
Current and Future Analysis of Rho Kinases Inhibitor Market With New Business Strategies and Forecas...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Alphacentric Lifesci that are available to investors today. That information is available publicly through Alphacentric media outlets and privately through word of mouth or via Alphacentric internal channels. However, regardless of the origin, that massive amount of Alphacentric data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Alphacentric Lifesci news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Alphacentric Lifesci relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Alphacentric Lifesci's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Alphacentric Lifesci alpha.

Other Information on Investing in Alphacentric Mutual Fund

Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules